Syngenta plans a series of meetings with investors as it contends with frustration from some shareholders over its rejection of a roughly $45 billion takeover effort by rival agribusiness giant Monsanto.
read more
Syngenta plans a series of meetings with investors as it contends with frustration from some shareholders over its rejection of a roughly $45 billion takeover effort by rival agribusiness giant Monsanto.
read more